叔丁基 N-(2-氟-4-碘苯基)氨基甲酸酯 | 886497-72-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 叔丁基 N-(2-氟-4-碘苯基)氨基甲酸酯
• 中文别名: N-BOC2-氟-4-碘苯胺；叔丁基N-(2-氟-4-碘苯基)氨基甲酸酯
• 英文名称: tert-butyl (2-fluoro-4-iodophenyl)carbamate
• 英文别名: tert-butyl 2-fluoro-4-iodophenylcarbamate；tert-butyl N-(2-fluoro-4-iodophenyl)carbamate
• CAS: 886497-72-9
• 化学式: C₁₁H₁₃FINO₂
• mdl: MFCD06797742
• 分子量: 337.133
• InChiKey: QPMNEDDPZQDRRB-UHFFFAOYSA-N

物化性质

• 熔点：
  52-55°C
• 沸点：
  288.7±30.0 °C(Predicted)
• 密度：
  1.646±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2924299090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: N-BOC 2-fluoro-4-iodoaniline
Synonyms: tert-Butyl 2-fluoro-4-iodophenylcarbamate

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: N-BOC 2-fluoro-4-iodoaniline
CAS number: 886497-72-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C11H13FINO2
Molecular weight: 337.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  叔丁基 N-(2-氟-4-碘苯基)氨基甲酸酯 在 bis-triphenylphosphine-palladium(II) chloride 、 RuH₂(CO)(PPh₃)₃ 、 1,1'-bis(diisopropylphosphino)ferrocene 、 4-硝基苯磺酸 、 四丁基碘化铵 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 1,4-双(二苯基膦)丁烷 作用下， 以 乙二醇二甲醚 、 二甲基亚砜 为溶剂， 反应 48.0h， 生成 tert-butyl (2-fluoro-4-(4-hydroxy-6-(5-methylfuran-2-yl)hex-1-en-3-yl)phenyl)carbamate
  参考文献：
  名称：

  1-芳基丙炔和醇的非对映和对映选择性钌催化 CC 偶联：炔烃作为手性烯丙基金属前体在羰基抗 (α-芳基) 烯丙基化中的作用

  摘要：

  高度易处理的 1-aryl-1-propynes，很容易通过 Sonogashira 偶联获得，在钌-JOSIPHOS 催化的抗非对映和对映选择性醛（α-芳基）烯丙基化与伯脂肪族或苄醇亲电子试剂中用作手性烯丙基金属亲核试剂。该方法能够收敛构建同烯丙基sec-带有叔苄基立体中心的苯乙醇。芳基磺酸添加剂的空间和电子特性均被证明有助于形成更具选择性和生产性的碘化物结合的钌催化剂的效率。正如同位素标记研究所证实的那样，双重催化过程是有效的，其中炔烃到丙二烯异构化之后是丙二烯-羰基通过氢自动转移进行还原偶联。观察到从这两个离散的催化事件中产生的氢化钌的交叉。该方法的实用性通过将选定的反应产物转化为相应的苯乙胺和新木脂素天然产物 (-)-山楂 A-D 的首次全合成来说明。

  DOI：

  10.1021/jacs.0c12242
• 作为产物：
  描述：

  二碳酸二叔丁酯 、 2-氟-4-碘苯胺 以 乙醇 为溶剂， 生成 叔丁基 N-(2-氟-4-碘苯基)氨基甲酸酯
  参考文献：
  名称：

  脲类化合物及其作为STING抑制剂的医药用途

  摘要：

  本发明公开了如式I所示的脲类化合物及其作为STING抑制剂的医药用途，本发明的式I化合物或其药学上可接受的盐可用于制备预防或治疗STING介导的疾病的药物。#imgabs0#

  公开号：

  CN117756698A

文献信息

• [EN] PYRIDAZINE DERIVATIVES AS FACTOR XIA INHIBITORS<br/>[FR] DÉRIVÉS DE LA PYRIDAZINE INHIBITEURS DU FACTEUR XIA
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2009114677A1

  公开（公告）日：2009-09-17

  The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein the variables A, L1, L2, R2, R11, and M are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of fXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.

  本发明提供了式（I）的化合物：或其立体异构体、互变异构体或药学上可接受的盐，其中变量A、L1、L2、R2、R11和M如本文所定义。这些化合物是选择性因子XIa抑制剂或fXIa和血浆激肽原的双重抑制剂。本发明还涉及包含这些化合物的药物组合物以及使用它们治疗血栓栓塞和/或炎症性疾病的方法。
• Enantioselective Ruthenium-BINAP-Catalyzed Carbonyl Reductive Coupling of Alkoxyallenes: Convergent Construction of <i>syn-sec,tert</i>-Diols via (<i>Z</i>)-σ-Allylmetal Intermediates
  作者：Ming Xiang、Dana E. Pfaffinger、Eliezer Ortiz、Gilmar A. Brito、Michael J. Krische

  DOI：10.1021/jacs.1c03480

  日期：2021.6.16

  The first catalytic enantioselective ruthenium-catalyzed carbonyl reductive couplings of allene pronucleophiles is described. Using an iodide-modified ruthenium-BINAP-catalyst and O-benzhydryl alkoxyallene 1a, carbonyl (α-alkoxy)allylation occurs from the alcohol or aldehyde oxidation level to form enantiomerically enriched syn-sec,tert-diols. Internal chelation directs intervention of (Z)-σ-alkoxyallylruthenium

  描述了丙二烯亲核试剂的第一个催化对映选择性钌催化羰基还原偶联。使用碘化物改性的钌-BINAP-催化剂和O-二苯甲基烷氧基丙二烯1a，从醇或醛氧化水平发生羰基（α-烷氧基）烯丙基化，形成对映异构体富集的顺链、叔二醇。内部螯合指导 ( Z )-σ-烷氧基烯丙基钌异构体的干预，其参与立体定向羰基加成。
• PYRIDAZINE DERIVATIVES AS FACTOR XIA INHIBITORS
  申请人：Corte James R.

  公开号：US20110021492A1

  公开（公告）日：2011-01-27

  The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein the variables A, L 1 , L 2 , R 2 , R 11 , and M are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of fXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.

  本发明提供公式（I）的化合物：或其立体异构体，互变异构体或药学上可接受的盐，其中变量A，L1，L2，R2，R11和M如本文所定义。这些化合物是选择性因子XIa抑制剂或fXIa和血浆卡利肽酶双重抑制剂。本发明还涉及包含这些化合物的制药组合物和使用它们治疗血栓栓塞和/或炎症性疾病的方法。
• US8324199B2
  申请人：——

  公开号：US8324199B2

  公开（公告）日：2012-12-04
• Diastereo- and Enantioselective Ruthenium-Catalyzed C-C Coupling of 1-Arylpropynes and Alcohols: Alkynes as Chiral Allylmetal Precursors in Carbonyl <i>anti</i>-(α-Aryl)allylation
  作者：Ming Xiang、Ankan Ghosh、Michael J. Krische

  DOI：10.1021/jacs.0c12242

  日期：2021.2.24

  pronucleophiles in ruthenium-JOSIPHOS-catalyzed anti-diastereo- and enantioselective aldehyde (α-aryl)allylations with primary aliphatic or benzylic alcohol proelectrophiles. This method enables convergent construction of homoallylic sec-phenethyl alcohols bearing tertiary benzylic stereocenters. Both steric and electronic features of aryl sulfonic acid additives were shown to contribute to the efficiency with

  高度易处理的 1-aryl-1-propynes，很容易通过 Sonogashira 偶联获得，在钌-JOSIPHOS 催化的抗非对映和对映选择性醛（α-芳基）烯丙基化与伯脂肪族或苄醇亲电子试剂中用作手性烯丙基金属亲核试剂。该方法能够收敛构建同烯丙基sec-带有叔苄基立体中心的苯乙醇。芳基磺酸添加剂的空间和电子特性均被证明有助于形成更具选择性和生产性的碘化物结合的钌催化剂的效率。正如同位素标记研究所证实的那样，双重催化过程是有效的，其中炔烃到丙二烯异构化之后是丙二烯-羰基通过氢自动转移进行还原偶联。观察到从这两个离散的催化事件中产生的氢化钌的交叉。该方法的实用性通过将选定的反应产物转化为相应的苯乙胺和新木脂素天然产物 (-)-山楂 A-D 的首次全合成来说明。